DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Synopsis of Open Program Funding Opportunities



FY22 Bone Marrow Failure Research Program (BMFRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award (IDA) Program Announcement
Application Instructions
May 5, 2022
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $450,000 in direct costs (plus indirect costs).
Pre-Application (Preproposal): June 29, 2022
5:00 p.m. Eastern Time (ET)

Application: September 23, 2022 11:59 p.m. ET
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions
May 5, 2022 Funding Level 1:
  • The maximum period of performance is 3 years.
  • Maximum funding of $600,000 in direct costs (plus indirect costs).

Funding Level 2: IND-enabling efforts
  • The maximum period of performance is 2  years.
  • Maximum funding of $800,000 in direct costs (plus indirect costs).
Pre-Application (Preproposal): June 29, 2022
5:00 p.m. Eastern Time (ET)

Application: September 23, 2022 11:59 p.m. ET

FY22 Breast Cancer Research Program (BCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Breakthrough Award Levels 1 and 2 II (BTA12-2) Program Announcement
Application Instructions
June 9, 2022 Funding Level 1:
  • Maximum funding of $450,000 for direct costs (plus indirect costs).
  • The maximum period of performance is years.

Funding Level 1 with Partnering PI Option:

  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • The maximum period of performance is years.

Funding Level 2:

  • Maximum funding of $1 million (M) for direct costs (plus indirect costs).
  • The maximum period of performance is years.

Funding Level 2 – Population Science and Prevention Studies:

  • Maximum funding of $1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is years.

Funding Level 2 with Partnering PI Option:

  • Maximum funding of $1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2 – Population Science and Prevention Studies – Partnering PI Option:

  • Maximum funding of $2M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
September 22, 2022 5:00 p.m. Eastern Time

Application:
October 6, 2022 11:59 p.m. Eastern Time
Era of Hope Scholar Award II (EOHS-2) Program Announcement
Application Instructions
June 9, 2022
  • Maximum funding of $3M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
September 22, 2022 5:00 p.m. Eastern Time

Application:
October 6, 2022 11:59 p.m. Eastern Time

Confidential Letters of Recommendation Submission Deadline:
October 11, 2022 5:00 p.m. Eastern Time
Breakthrough Award Level 3 II (BTA3-2) Program Announcement
Application Instructions
June 9, 2022 Funding Level 3:
  • Maximum funding of $4M in direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.

Funding Level 3 with Partnering PI Option:

  • Maximum funding of $5M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal):
August 3, 2022 5:00 p.m. Eastern Time

Invited Application:
November 2, 2022 11:59 p.m. Eastern Time
Breakthrough Award Level 4 II (BTA4-2) Program Announcement
Application Instructions
June 9, 2022 Funding Level 4 and Funding Level 4 with Partnering PI Option:
  • Maximum funding of $10M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal):
August 3, 2022 5:00 p.m. Eastern Time

Invited Application:
November 2, 2022 11:59 p.m. Eastern Time
Innovator Award II (INNOV-2) Program Announcement
Application Instructions
June 9, 2022
  • Maximum funding of $7M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal):
August 3, 2022 5:00 p.m. Eastern Time

Invited Application:
November 2, 2022 11:59 p.m. Eastern Time

Confidential Letters of Recommendation Submission Deadline:
November 4, 2022 5:00 p.m. Eastern Time
Transformative Breast Cancer Consortium Award II (TBCCA-2) Program Announcement
Application Instructions
May 24, 2022
  • Maximum funding of $25M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal):
August 3, 2022 5:00 p.m. Eastern Time

Invited Application:
November 2, 2022 11:59 p.m. Eastern Time

FY21 Chronic Pain Management Research Program (CPMRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Exploration Award (CEA) Program Announcement
Application Instructions
May 26, 2022
  • The maximum allowable funding for the entire period of performance is $250,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 2 years.
Pre-Application (Preproposal):
July 12, 2022 5:00 p.m. Eastern Time

Application:
October 13, 2022 11:59 p.m. Eastern Time
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions
May 26, 2022
  • The maximum allowable funding for the entire period of performance is $900,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal):
July 12, 2022 5:00 p.m. Eastern Time

Application:
October 13, 2022 11:59 p.m. Eastern Time
Translational Research Award (TRA) Program Announcement
Application Instructions
May 26, 2022
  • The maximum allowable funding for the entire period of performance is $1,400,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal):
July 12, 2022 5:00 p.m. Eastern Time

Application:
October 13, 2022 11:59 p.m. Eastern Time

FY22 Combat Readiness – Medical Research Program (CRRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Rapid Development and Translational Research Award (RDTRA) Extramural applicants:
Broad Agency Announcement
General Submission Instructions

Intramural applicants:
Program Announcement Announcement
May 9, 2022 RDTRA:
  • Maximum funding of $2,200,000 for total costs (to include direct and indirect costs).
  • Maximum period of performance is 2 years.
RDTRA with Option:
  • Maximum funding of $2,200,000 (RDTRA) and 1,000,000 (Option) for total costs (to include direct and indirect costs).
  • Maximum period of performance is 2 years for the RDTRA base award and 1 year for the Option.
Pre-Application (Preproposal):
June 23, 2022 5:00 p.m. Eastern Time

Proposal/Application:
September 14, 2022 11:59 p.m. Eastern Time
DMDRP

FY22 Duchenne Muscular Dystrophy Research Program (DMDRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award (IDA) Program Announcement
Application Instructions
June 7, 2022
  • Maximum funding of $350,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
Pre-Application (Preproposal):
August 3, 2022 5:00 p.m. Eastern Time (ET)

Application:
November 15, 2022 11:59 p.m. ET
Translational Research Award (TRA) Program Announcement
Application Instructions
June 7, 2022
  • Maximum funding of $1,250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

Early-Career Partnering PI Option:
  • Maximum funding of $1,350,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal):
August 3, 2022 5:00 p.m. Eastern Time (ET)

Application:
November 15, 2022 11:59 p.m. ET

FY22 Hearing Restoration Research Program (HRRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Focused Research Award (FRA) Program Announcement
Application Instructions
May 18, 2022 Funding Level 1:
  • Maximum funding of $250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Funding Level 2:
  • Maximum funding of $1,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Funding Level 3:
  • Maximum funding of $1,250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal):
July 22, 2022
5:00 p.m. Eastern Time

Application:
November 30, 2022
11:59 p.m. Eastern time

FY22 Kidney Cancer Research Program (KCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Academy of Kidney Cancer Investigators – Early-Career Scholar Award (AKCIECSA) Program Announcement
Application Instructions
June 16, 2022
  • Maximum funding of $725,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
September 29, 2022
5:00 p.m. Eastern Time

Application:
October 20, 2022
11:59 p.m. Eastern Time
Nurse-Initiated Research Award (NIRA) Program Announcement
Application Instructions
June 16, 2022
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
September 29, 2022
5:00 p.m. Eastern Time

Application:
October 20, 2022
11:59 p.m. Eastern Time
Clinical Trial Award (CTA) Program Announcement
Application Instructions
June 16, 2022
  • Maximum funding of $1,500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Cell Therapy Focus Option:
  • Maximum funding of $2,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
September 29, 2022
5:00 p.m. Eastern Time

Application:
October 20, 2022
11:59 p.m. Eastern Time
LCRP

FY22 Lung Cancer Research Program (LCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Translational Research Partnership Award (CTRPA) Program Announcement
Application Instructions
March 16, 2022
  • Maximum combined funding of $1,200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Letter of Intent):
July 13, 2022 5:00 p.m. Eastern Time

Letter of Intent is required.

Application:
July 27, 2022 11:59 p.m. Eastern Time
LRP

FY22 Lupus Research Program (LRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Award (IA) Program Announcement
Application Instructions
May 17, 2022
  • The maximum allowable funding for the entire period of performance is $300,000 in total costs (direct plus indirect costs).
  • The maximum period of performance is 2 years.
Pre-Application (Letter of Intent):
August 16, 2022
5:00 p.m. Eastern Time (ET)

Application:
September 1, 2022
11:59 p.m. ET
Impact Award (IPA) Program Announcement
Application Instructions
May 17, 2022
  • The maximum allowable funding for the entire period of performance is $750,000 in total costs (direct plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
August 16, 2022
5:00 p.m. Eastern Time (ET)

Application:
September 1, 2022
11:59 p.m. ET
Transformative Vision Award (TVA) Program Announcement
Application Instructions
May 17, 2022
  • The maximum allowable funding for the entire period of performance is $2,500,000 in total costs (direct plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
August 16, 2022
5:00 p.m. Eastern Time (ET)

Application:
September 1, 2022
11:59 p.m. ET

FY22 Melanoma Research Program (MRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Award (IA) Program Announcement
Application Instructions
June 3, 2022
  • The maximum allowable funding for the entire period of performance is $500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Preproposal):
July 8, 2022
5:00 p.m. Eastern Time (ET)

Application:
October 5, 2022
11:59 p.m. ET
Melanoma Academy Scholar Award (MASA) Program Announcement
Application Instructions
June 3, 2022
  • The maximum allowable funding for the entire period of performance is $550,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Letter of Intent):
September 14, 2022
5:00 p.m. ET

Application:
October 5, 2022
11:59 p.m. ET
Mid-Career Accelerator Award (MCAA) Program Announcement
Application Instructions
June 3, 2022
  • The maximum allowable funding for the entire period of performance is $725,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Letter of Intent):
September 14, 2022
5:00 p.m. ET

Application:
October 5, 2022
11:59 p.m. ET
Team Science Award (TSA) Program Announcement
Application Instructions
June 3, 2022
  • The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Letter of Intent):
September 14, 2022
5:00 p.m. ET

Application:
October 5, 2022
11:59 p.m. ET
Focused Program Award – Rare Melanomas (FPA) Program Announcement
Application Instructions
June 3, 2022
  • The maximum allowable funding for the entire period of performance is $2,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
September 14, 2022
5:00 p.m. ET

Application:
October 5, 2022
11:59 p.m. ET
MBRP

FY22 Military Burn Research Program (MBRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Translational Research Award (CTRA) Program Announcement
Application Instructions
May 26, 2022
  • The maximum allowable funding for the entire period of performance is $2.21 million for total costs (direct costs plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal):
June 27, 2022 5:00 p.m. Eastern Time

Invitation to Submit an Application:
August 12, 2022

Application:
October 11, 2022 11:59 p.m. Eastern Time
Technology/Therapeutic Development Award (TTDA) Program Announcement
Application Instructions
May 26, 2022
  • The maximum allowable funding for the entire period of performance is $2.21 million for total costs (direct costs plus indirect costs).
  • The maximum period of performance is 3 years.
Pre-Application (Preproposal):
June 27, 2022 5:00 p.m. Eastern Time

Invitation to Submit an Application:
August 12, 2022

Application:
October 11, 2022 11:59 p.m. Eastern Time
MSRP

FY22 Multiple Sclerosis Research Program (MSRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award (CTA) Program Announcement
Application Instructions
April 29, 2022 The FY22 CTA offers two funding levels:

Funding Level 1

  • Maximum funding of $1.6M for total costs.
  • Maximum period of performance is 3 years.

Funding Level 2

  • Maximum funding of $4.5M for total costs.
  • Maximum period of performance is 4 years.
Pre-Application (Preproposal): June 23, 2022
5:00 p.m. Eastern Time
Application: October 3, 2022 11:59 p.m. Eastern Time
Early Investigator Research Award (EIRA) Program Announcement
Application Instructions
April 29, 2022
  • Maximum funding of $320,000 for total costs.
  • Maximum period of performance is 2 years.
Pre-Application (Letter of Intent): August 2, 2022
5:00 p.m. Eastern Time
Confidential Letters of Recommendation: October 6, 2022 5:00 p.m. Eastern Time
Application: October 3, 2022 11:59 p.m. Eastern Time
Exploration - Hypothesis Development Research Award (EHDA) Program Announcement
Application Instructions
April 29, 2022
  • Maximum funding of $250,000 for total costs.
  • Maximum period of performance is 2 years.
Pre-Application (Preproposal): June 23, 2022
5:00 p.m. Eastern Time
Application: October 3, 2022 11:59 p.m. Eastern Time
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions
April 29, 2022
  • Maximum funding of $1M for total costs.
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal): June 23, 2022
5:00 p.m. Eastern Time
Application: October 3, 2022 11:59 p.m. Eastern Time

FY22 Neurofibromatosis Research Program (NFRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award (CTA) Program Announcement
Application Instructions
April 11, 2022
  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $800,000 in direct costs ($1,000,000 in direct costs if requesting the Qualified Collaborator Option).
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
June 30, 2022 5:00 p.m. Eastern Time

Application:
July 21, 2022 11:59 p.m. ET
Early Investigator Research Award (EIRA) Program Announcement
Application Instructions
April 11, 2022
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $200,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
June 30, 2022 5:00 p.m. Eastern Time

Application:
July 21, 2022 11:59 p.m. ET

Confidential Letters of Recommendation:
July 26, 2022 5:00 p.m. ET

Exploration - Hypothesis Development Award (EHDA) Program Announcement
Application Instructions
April 11, 2022
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $100,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
June 30, 2022 5:00 p.m. Eastern Time

Application:
July 21, 2022 11:59 p.m. ET
New Investigator Award (NIA) Program Announcement
Application Instructions
April 11, 2022
  • The maximum period of performance is years.
  • The maximum allowable funding for the entire period of performance is $450,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
June 30, 2022 5:00 p.m. Eastern Time

Application:
July 21, 2022 11:59 p.m. ET
Synergistic Idea Award (SIA) Program Announcement
Application Instructions
April 11, 2022
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $2,000,000 in direct costs.
Pre-Application (Letter of Intent):
June 30, 2022 5:00 p.m. Eastern Time

Application:
July 21, 2022 11:59 p.m. ET
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions
April 11, 2022
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $525,000 in direct costs.
  • The maximum allowable funding for applications including either the Optional Qualified Collaborator or the NF-OSI Option is $575,000 in direct costs.
  • The maximum allowable funding for applications including both the Optional Qualified Collaborator Option and the NF-OSI Option is $625,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
June 30, 2022 5:00 p.m. Eastern Time

Application:
July 21, 2022 11:59 p.m. ET

FY22 Parkinson’s Research Program (PRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award (EIRA) Program Announcement
Application Instructions
June 1, 2022
  • Maximum funding of $400,000 for total costs (includes direct and indirect costs).
  • Maximum period of performance is 2 years.
Pre-Application (Letter of Intent):
August 16, 2022
5:00 p.m. Eastern Time

Application: September 1, 2022
11:59 p.m. Eastern Time
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions
June 1, 2022
  • Maximum funding of $1.2 million (M) for total costs (includes direct and indirect costs).
  • Maximum Period of performance is 3 years.
Pre-Application (Letter of Intent):
August 16, 2022
5:00 p.m. Eastern Time

Application: September 1, 2022
11:59 p.m. Eastern Time
Synergistic Idea Award (SIA) Program Announcement
Application Instructions
June 1, 2022
  • Maximum funding of $3 million (M) for total costs (includes direct and indirect costs).
  • Maximum Period of performance is 4 years.
Pre-Application (Letter of Intent):
August 16, 2022
5:00 p.m. Eastern Time

Application: September 1, 2022
11:59 p.m. Eastern Time

FY22 Pancreatic Cancer Research Program (PCARP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award (IDA) Program Announcement
Application Instructions
April 26, 2022 Established Single PI Option:
  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

Early-Career Investigator Partnering PI Option:

  • Maximum funding of $650,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal):
July 8, 2022 5:00 p.m. Eastern Time

Application:
October 6, 2022 11:59 p.m. Eastern Time
Translational Research Partnership Award (TRPA) Program Announcement
Application Instructions
April 26, 2022
  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal):
July 8, 2022 5:00 p.m. Eastern Time

Application:
October 6, 2022 11:59 p.m. Eastern Time

FY22 Peer Reviewed Cancer Research Program (PRCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Behavioral Health Science Award (BHSA) Program Announcement
Application Instructions
March 31, 2022
  • The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent): July 12, 2022 5:00 p.m. Eastern Time

Application: August 2, 2022
11:59 p.m. Eastern Time
Career Development Award (CDA) – Fellow Option Program Announcement
Application Instructions
March 31, 2022
  • The maximum allowable funding for the entire period of performance is $400,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Letter of Intent): July 12, 2022 5:00 p.m. Eastern Time

Application: August 2, 2022
11:59 p.m. Eastern Time
Career Development Award (CDA) – Virtual Cancer Center Scholar Option Program Announcement
Application Instructions
March 31, 2022
  • Maximum funding for the entire period of performance is $800,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Letter of Intent): July 12, 2022 5:00 p.m. Eastern Time

Application: August 2, 2022
11:59 p.m. Eastern Time
Translational Team Science Award (TTSA) Program Announcement
Application Instructions
March 31, 2022
  • The maximum allowable funding for the entire period of performance is $2,500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent): July 12, 2022 5:00 p.m. Eastern Time

Application: August 2, 2022
11:59 p.m. Eastern Time
Convergent Science Cancer Consortium Development Award (CSCCDA) Program Announcement
Application Instructions
March 31, 2022
  • The maximum allowable funding for the entire period of performance is $2,500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent): August 17, 2022 5:00 p.m. Eastern Time

Application: September 7, 2022
11:59 p.m. Eastern Time

FY22 Prostate Cancer Research Program (PCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award (EIRA) Program Announcement
Application Instructions
April 5, 2022
  • The maximum allowable funding for the entire period of performance is $300,000 for direct costs.
  • The maximum period of performance is 2 years.
Pre-Application (LOI):
July 7, 2022
5:00 p.m. Eastern Time

Application:
July 28, 2022
11:59 p.m. Eastern Time

Letters of Recommendation:
August 2, 2022
5:00 p.m. Eastern Time
Physician Research Award (PRA) Program Announcement
Application Instructions
April 5, 2022
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • The maximum period of performance is 4 years.
Pre-Application (LOI):
July 7, 2022
5:00 p.m. Eastern Time

Application:
July 28, 2022
11:59 p.m. Eastern Time

Letters of Recommendation:
August 2, 2022
5:00 p.m. Eastern Time
Translational Science Award (TSA) Program Announcement
Application Instructions
April 5, 2022
  • The maximum allowable funding for the entire period of performance is $900,000 for direct costs.
  • The maximum period of performance is 3 years.
Pre-Application (LOI):
August 4, 2022
5:00 p.m. Eastern Time

Application:
August 25, 2022
11:59 p.m. Eastern Time
Health Disparity Research Award (HDRA) Program Announcement
Application Instructions
April 5, 2022
  • The maximum allowable funding for the entire period of performance is $900,000 for direct costs.
  • The maximum period of performance is 3 years.
Pre-Application (LOI):
August 4, 2022
5:00 p.m. Eastern Time

Application:
August 25, 2022
11:59 p.m. Eastern Time
Idea Development Award (IDA) Program Announcement
Application Instructions
April 5, 2022
  • The maximum allowable funding for the entire period of performance is $900,000 for direct costs.
  • The maximum period of performance is 3 years.
Pre-Application (LOI):
July 7, 2022
5:00 p.m. Eastern Time

Application:
July 28, 2022
11:59 p.m. Eastern Time
Data Science Award (DSA) Program Announcement
Application Instructions
April 5, 2022
  • The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs.
  • The maximum period of performance is 3 years.
Pre-Application (LOI):
August 4, 2022
5:00 p.m. Eastern Time

Application:
August 25, 2022
11:59 p.m. Eastern Time

FY22 Rare Cancers Research Program (RCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Concept Award (CA) Program Announcement
Application Instructions
April 21, 2022
  • Maximum funding of $100,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 1 year.
Pre-Application (Letter of Intent):
July 18, 2022
5:00 p.m. Eastern Time (ET)

Application:
August 29, 2022
11:59 p.m. ET
Idea Development Award (IDA) Program Announcement
Application Instructions
April 21, 2022
  • Maximum funding of $350,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal):
June 22, 2022
5:00 p.m. Eastern Time (ET)

Application:
September 30, 2022
11:59 p.m. ET
Resource and Community Development Award (RCDA) Program Announcement
Application Instructions
April 21, 2022
  • Maximum funding of $600,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal):
June 22, 2022
5:00 p.m. Eastern Time (ET)

Application:
September 30, 2022
11:59 p.m. ET

FY22 Reconstructive Transplant Research Program (RTRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions
June 15, 2022 Single PI:
  • Maximum funding of $1 million (M) for total costs (direct plus indirect costs).
  • Maximum period of performance is years.
Multiple PI Option:
  • Maximum total funding of $1.5M for total costs (direct plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal):
July 27, 2022
5:00 p.m. Eastern Time (ET)

Application:
October 19, 2022
11:59 p.m. ET
Advanced Technology Development Award (ATDA) Program Announcement
Application Instructions
June 15, 2022 Single PI:
  • Maximum funding of $1M for total costs (direct plus indirect costs).
  • Maximum period of performance is years.
Multiple PI Option:
  • Maximum total funding of $1.5M for total costs (direct plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal):
July 27, 2022
5:00 p.m. Eastern Time (ET)

Application:
October 19, 2022
11:59 p.m. ET
Concept Award (CA) Program Announcement
Application Instructions
June 15, 2022
  • Maximum funding of $200,000 for total costs.
  • Maximum period of performance is 18 months.
Pre-Application (Letter of Intent):
September 28, 2022
5:00 p.m. ET

Application:
October 19, 2022
11:59 p.m. ET

FY22 Tuberous Sclerosis Complex Research Program (TSCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Exploration Hypothesis Development Award (EHDA) Program Announcement
Application Instructions
March 31, 2022
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $150,000 in direct costs.
  • Indirect costs may be proposed in accordance With the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 30, 2022
5:00 p.m. Eastern Time (ET)

Application:
July 28, 2022 11:59 p.m. ET
Idea Development Award (IDA) Program Announcement
Application Instructions
March 31, 2022
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $500,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 30, 2022
5:00 p.m. Eastern Time (ET)

Application:
July 28, 2022 11:59 p.m. ET
Clinical Translational Research Award (CTRA) Program Announcement
Application Instructions
March 31, 2022
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $1,000,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 30, 2022
5:00 p.m. Eastern Time (ET)

Application:
July 28, 2022 11:59 p.m. ET

FY22 Vision Research Program (VRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award (CTA) Program Announcement
Application Instructions
May 12, 2022
  • The maximum allowable funding for the entire period of performance is $1,600,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
Pre-Application (Preproposal):
July 15, 2022
5:00 p.m. Eastern Time

Application: November 9, 2022
11:59 p.m. Eastern Time
Focused Translational Team Science Award (FTTSA) Program Announcement
Application Instructions
May 12, 2022
  • The maximum allowable funding for the entire period of performance is $4,000,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal):
July 15, 2022
5:00 p.m. Eastern Time

Application: November 9, 2022
11:59 p.m. Eastern Time
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions
May 12, 2022 Funding Level 1:
  • The maximum allowable funding for the entire period of performance is $260,000 for direct costs (plus indirect costs).
  • The maximum period of performance is years.

Funding Level 2:

  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
Pre-Application (Preproposal):
July 15, 2022
5:00 p.m. Eastern Time

Application: November 9, 2022
11:59 p.m. Eastern Time
Translational Research Award (TRA) Program Announcement
Application Instructions
May 12, 2022
  • The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
Pre-Application (Preproposal):
July 15, 2022
5:00 p.m. Eastern Time

Application: November 9, 2022
11:59 p.m. Eastern Time